Eos Management LP’s Thermo Fisher Scientific TMO Stock Holding History

Eos Management LP’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,483	Closed	-$4.72M	–	47
2025 Q1	$4.72M	Buy	+9,483	New	+$5.14M	2.11%	17

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Eos Management LP's TMO Position: Q2 2025 in Review

Eos Management LP sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 9,483 shares — an estimated $4.72M sold.

Eos Management LP first reported a position in TMO in Q1 2025 and held it in 1 quarter. The position peaked at $4.72M in Q1 2025. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Eos Management LP reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Eos Management LP sold 9,483 Thermo Fisher Scientific shares in Q2 2025, an estimated $4.72M.
Eos Management LP first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 1 quarter.
Eos Management LP's Thermo Fisher Scientific position peaked at $4.72M in Q1 2025.
2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Eos Management LP's 13F filing for Q2 2025, filed 29 Jul 2025.